CA
WST icon

Continuum Advisory’s West Pharmaceutical WST Stock Holding History

Continuum Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$224 – 1588
2025
Q1 		$224 Sell
1
-3
-75% -$827 ﹤0.01% 1623
2024
Q4 		$1.31K Buy
4
+1
+33% +$315 ﹤0.01% 1557
2024
Q3 		$1.01K Buy
+3
New +$919 ﹤0.01% 1618
2024
Q2 		– Sell
-1
Closed -$366 – 1753
2024
Q1 		$366 Buy
+1
New +$370 ﹤0.01% 1643

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Continuum Advisory's WST Position: Q2 2025 in Review

Continuum Advisory sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 1 share — an estimated $224 sold.

Continuum Advisory first reported a position in WST in Q1 2024 and held it in 4 quarters. The position peaked at $1.31K in Q4 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Continuum Advisory reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 1 West Pharmaceutical share in Q2 2025, an estimated $224.
  • Continuum Advisory first reported a position in West Pharmaceutical in Q1 2024 and held it in 4 quarters.
  • Continuum Advisory's West Pharmaceutical position peaked at $1.31K in Q4 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.